Pediatric Neurology
Volume 30, Issue 4 , Pages 236-243 , April 2004

Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy

  • Berten P.G.M Ceulemans, MD

      Affiliations

    • Department of Molecular Genetics, University of Antwerp, Antwerpen, Belgium
    • Department of Neurology-Child Neurology, University Hospital Antwerp (UZA), Antwerpen, Belgium
    • Epilepsy Center for Children and Youth, Pulderbos, Belgium
    • Corresponding Author InformationCommunications should be addressed to:Dr. Ceulemans; Epilepsy Genetics Project; Department of Molecular Genetics; University of Antwerp; Universiteitsplein 1; B-2610 Wilrijk; Belgium.
    • ,
  • Lieve R.F Claes, MSc

      Affiliations

    • Department of Molecular Genetics, University of Antwerp, Antwerpen, Belgium
    • ,
  • Lieven G Lagae, MD, PhD

      Affiliations

    • Epilepsy Center for Children and Youth, Pulderbos, Belgium
    • Department of Pediatric Neurology, University Hospital Gasthuisberg, Leuven, Belgium

Received 27 May 2003 ,Accepted 20 October 2003.

References 

  1. Dravet C. Les épilepsies graves de l'enfant. Vie Méd. 1978;8:543–548
  2. Engel J. International League Against Epilepsy (ILAE) Commission Report. Epilepsia. 2001;42:796–803
  3. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy (Dravet syndrome). In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence, 3rd ed. Eastleigh, UK: John Libbey & Co. Ltd, 2002:81-103
  4. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327–1332
  5. Sugawara T, Mazaki-Miyazaki E, Fukushima K, et al.  Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology. 2002;58:1122–1124
  6. Ohmori I, Ouchida M, Ohtsuka Y, Oka E, Shimizu K. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem Biophys Res Commun. 2002;295:17–23
  7. Claes L, Ceulemans B, Audenaert D, et al.  De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Human Mutation. 2003;21:615–621
  8. Scheffer I, Berkovic S. Generalized epilepsy with febrile seizures plus (A genetic disorder with heterogeneous clinical phenotypes). Brain. 1997;120:479–490
  9. Wallace R, Wang D, Singh R, et al.  Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel β1-subunit gene SCN1B. Nat Genet. 1998;19:366–370
  10. Singh R, Andermann E, Whitehouse WPA, et al.  Severe myoclonic epilepsy of infancy (Extended spectrum of GEFS+?). Epilepsia. 2001;42:837–844
  11. Sugawara T, Mazaki-Miyazaki E, Ito M, et al.  Nav1.1 mutations cause febrile seizures associated with afebrile partial seizures. Neurology. 2001;57:703–705
  12. Wallace RH, Marini C, Petrou S, et al.  Mutant GABA A receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet. 2001;28:49–52
  13. Harkin LA, Bowser DN, Dibbens LM, et al.  Truncation of the GABAA-receptor γ2- subunit in a family with generalized epilepsy with febrile seizures Plus. Am J Hum Genet. 2002;70:530–536
  14. Marini C, Harkin LA, Wallace RH, Mulley JC, Scheffer IE, Berkovic SF. Childhood absence epilepsy and febrile seizures (A family with a GABA A receptor mutation). Brain. 2003;126:230–240
  15. Wallace RH, Scheffer IE, Barnett S, et al.  Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2001;68:859–865
  16. Wallace RH, Scheffer IE, Parasivam G, et al.  Generalized epilepsy with febrile seizures plus (Mutation of the sodium channel subunit SCN1B). Neurology. 2002;58:1426–1429
  17. Escayg A, MacDonald BT, Meisler MH, et al.  Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet. 2000;24:343–345
  18. Escayg A, Heils A, MacDonald BT, Haug K, Sander T, Meisler MH. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus and prevalence of variants in patients with epilepsy. Am J Hum Genet. 2001;68:866–873
  19. Abou-Khalil B, Ge Q, Desai R, et al.  Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology. 2001;57:2265–2272
  20. Lossin C, Wang DW, Rhodes TH, Vanoye CG, George AL. Molecular basis of an inherited epilepsy. Neuron. 2002;34:877–884
  21. Spampanato J, Escayg A, Meisler MH, Goldin AL. Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J Neurosci. 2001;21:7481–7490
  22. Baulac S, Huberfeld G, Gourfinkel-An I, et al.  First genetic evidence of GABA A receptor dysfunction in epilepsy (A mutation in the γ2-subunit gene). Nat Genet. 2001;28:46–48
  23. Sugawara T, Tsurubuchi Y, Lal Agarwala K, et al.  A missense mutation of the Na+ channel αII-subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. PNAS. 2001;98:6384–6389
  24. Ophoff RA, Terwindt GM, Frants RR, Ferrari MD. P/Q-type Ca2+ channel defects in migraine, ataxia and epilepsy. (Review). Trends Pharmacol Sci. 1998;19:121–127
  25. Lopes-Cendes I, Scheffer IE, Berkovic SF, Rousseau M, Andermann E, Rouleau GA. A new locus for generalized epilepsy with febrile seizures plus maps to chromosome 2. Am J Hum Genet. 2000;66:698–701
  26. Baulac S, Gourfinkel-An I, Picard F, et al.  A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet. 1999;65:1078–1085
  27. Moulard B, Guipponi M, Chaigne D, Mouthon D, Buresi C, Malafosse A. Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33. Am J Hum Genet. 1999;65:1396–1400
  28. Singh R, Andermann E, Whitehouse WP, et al.  Severe myoclonic epilepsy of infancy (Extended spectrum of GEFS+?). Epilepsia. 2001;42:837–844
  29. Doose H, Lunau H, Castiglione E, Waltz S. Severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics. 1998;29:229–238
  30. Kanazawa O. Refractory grand mal seizures with onset during infancy including severe myoclonic epilepsy in infancy. Brain Devel. 2001;23:749–756
  31. Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal LR. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure. 2000;9:590–594
  32. Chiron C, Marchand MC, Tran A, et al.  Stiripentol in severe myoclonic epilepsy in infancy (A randomised placebo-controlled syndrome-dedicated trial. STICLO study group). Lancet. 2000;356(9242):1638–1642
  33. Coppola G, Capovilla G, Montagnini A, et al.  Topiramate as add-on drug in severe myoclonic epilepsy in infancy (An Italian multicenter open trial). Epilepsy Res. 2002;49:45–48
  34. Alekov AK, Rahman M, Mitrovic N, Lehmann-Horn F, Lerche H. Short communication. Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur J Neurosci. 2001;13:2171–2176
  35. Alekov AK, Rahman M, Mitrovic N, Lehmann-Horn F, Lerche H. Rapid Report. A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro. J Physiol 2000;529:533-9
  36. Spampanato J, Escayg A, Meisler MH, Goldin AL. Generalized epilepsy with febrile seizures plus type 2 mutation W1204R alters voltage-dependent gating of Na(v) 1.1 sodium channels. Neuroscience. 2003;16:37–48

PII: S0887-8994(03)00579-4

doi: 10.1016/j.pediatrneurol.2003.10.012

Pediatric Neurology
Volume 30, Issue 4 , Pages 236-243 , April 2004

Article Tools

* Image Usage & Resolution